Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1994-06-03
1996-12-31
Jones, W. Gary
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
536 231, 536 2433, 4353201, 4352523, 43525233, C12Q 168, C07H 2104, C07H 2102, A61K 3900
Patent
active
055893341
ABSTRACT:
A nucleic acid molecule which codes for a tumor rejection antigen precursor which is in turn processed to an antigen presented by HLA-B44 molecule is described. The antigen is also described. These materials are useful in diagnostic and therapeutic methodologies. The tumor rejection antigen precursor is not tyrosinase, which has previously been identified as a tumor rejection antigen precursor processed to an antigen presented by HLA-B44.
REFERENCES:
patent: 5342774 (1994-08-01), Boon et al.
Hans Schreiber, In Fundamental Immunology 2nd Edition, Ed by William E. Paul, Raven Press, Ltd., N.Y., 1989, pp. 924-955.
Van der Bruggen et al., "A Gene Encoding an Antigen Recognized By Cytolytic T Lymphocytes On a Human Melanoma", Science, 254:1643-1647 (Dec. 1991).
Khanna et al., "Localization of Epstein-Barr Virus Cytotoxic T Cell Epitopes Using Recombinant Vaccinia: Implications for Vaccine Development", J. Exp. Med., 176: 169-176 (Jul. 1992.
Boon-Falleur Thierry
Coulie Pierre
Jones W. Gary
Ludwig Institute for Cancer Research
Rees Dianne
LandOfFree
Isolated nucleic acid molecule which codes for a tumor rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated nucleic acid molecule which codes for a tumor rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated nucleic acid molecule which codes for a tumor rejection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1141223